BMVVF yields 4587.16% · JNJ yields 2.13%● Live data
📍 BMVVF pulled ahead of the other in Year 1
Combined, BMVVF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BMVVF + JNJ for your $10,000?
Bathurst Metals Corp., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties in Canada. The company explores for gold, silver, lead, copper, nickel, cobalt, platinum, and palladium deposits. It holds 100% interests in the Turner Lake property comprising approximately 3,500 hectares; the TED project covers approximately 2,644 hectares; the Gela Lake project consists of 2 mining blocks that covers approximately 3,116.39 hectares; the McAvoy Lake project comprises 3 claim blocks covering approximately 3,661.75 hectares; McGregor Lake property comprising 11 claim blocks that cover approximately 13,709.24 hectares; and the Speers Lake Project includes a claim block that covers approximately 875 staked hectares located in the south of Kugluktuk in Nunavut, Canada. The company was formerly known as Pacific Cascade Minerals Inc. and changed its name to Bathurst Metals Corp. in August 2020. Bathurst Metals Corp. was incorporated in 2006 and is based in Gibsons, Canada.
Full BMVVF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.